Liver Support for Sepsis-Related Liver Injury
Part of Digestive system clinical trials.
This trial looks at a condition called sepsis-associated liver injury (SALI), where the liver is damaged during a severe infection. It tests whether providing liver support can help patients. You may qualify if you have this specific liver problem and are already receiving liver support.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with sepsis-associated liver injury (SALI, meaning liver damage caused by a severe infection).
- You are receiving or willing to receive liver support treatment (like a machine that helps clean your blood or medicines to support liver function).
- You do not have thyroid disease (a problem with your thyroid gland).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with chronic liver disease who develop a serious infection called sepsis. The goal is to learn more about how to better treat or manage this condition.
This trial tests two different blood-filtering treatments for people with severe liver failure who are waiting for or unable to receive a liver transplant. It aims to see how these treatments affect blood clotting, inflammation, and organ function.
This trial tests if a special blood-filtering method combined with plasma exchange can help people with severe liver failure and sepsis. It aims to reduce inflammation and improve survival.
This study analyzes gene activity in patients with severe liver failure or sepsis to understand why some recover and others don't. It may lead to better treatments in the future.
This study looks at how bacteria in your gut and other signs in your body affect liver and kidney damage in people with sepsis. It also compares findings to healthy volunteers to see what is different.
This trial tests if a special fluid given through a vein can protect and repair the lining of your blood vessels during sepsis. Sepsis is a dangerous reaction to an infection that can damage organs. This study aims to see if this treatment helps patients in the intensive care unit (ICU) recover better.
Hear when a new Liver Injuries trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.